Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 62.55 ($0.84) and last traded at GBX 65 ($0.87), with a volume of 16002 shares. The stock had previously closed at GBX 66 ($0.88).
Arecor Therapeutics Price Performance
The firm has a market cap of £24.54 million, a P/E ratio of -235.71 and a beta of -0.17. The stock’s 50-day moving average is GBX 83.53 and its 200-day moving average is GBX 115.61. The company has a quick ratio of 6.24, a current ratio of 2.17 and a debt-to-equity ratio of 3.55.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Lennar Stock Could Be the Best Play in the Housing Market
- 3 Warren Buffett Stocks to Buy Now
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are Dividend Champions? How to Invest in the Champions
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
